Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators

NCT00035490 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT00035490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00035490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2001
Completion date
April 30, 2004
Enrollment
633 (actual)
Sites
142

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia